Avantium NV (AVTX) EUR0.1

Sell:€1.74Buy:€1.75€0.04 (2.46%)

Prices delayed by at least 15 minutes
Sell:€1.74
Buy:€1.75
Change:€0.04 (2.46%)
Prices delayed by at least 15 minutes
Sell:€1.74
Buy:€1.75
Change:€0.04 (2.46%)
Prices delayed by at least 15 minutes

Company Information

About this company

Avantium NV, formerly Avantium Holding BV, is a company based in the Netherlands engaged in environmental research and development (R&D). The Company develops chemical technologies and production processes to convert bio-based feedstock into sustainable products. The Company's business comprises three segments: Catalysis, Renewable Chemistries, and YXY. Catalysis segment provides catalysis R&D services and systems to chemical, refinery and energy companies, utilizing its Flowrence Technology Platform to devise the appropriate catalyst testing solutions. Renewable Chemistries is the development division with a portfolio of projects focusing on the conversion of biomass to chemical building blocks and plastic materials. The YXY segment comprises the activities of Syviana, the joint venture with BASF SE. The YXY technology is used to convert plant-based sugars into chemical building blocks for plastics, such as polymer polyethylenefuranoate (PEF), and other applications.

Key people

Edwin Moses
Independent Chairman of the Supervisory Board
Tom B. van Aken
Chief Executive Officer, Member of the Management Board
Margret G. Kleinsman
Independent Vice Chairman of the Supervisory Board
Bart J.J.V. Welten
Chief Financial Officer, Member of the Management Board
Gert-Jan M. Gruter
Chief Technology Officer
Carmen Helena Portocarero
General Counsel
Bas Blom
Managing Director - Avantium Renewable Polymers
Steven Olivier
Managing Director - Avantium Catalysis
Cynthia A. Arnold
Independent Member of the Supervisory Board
Michelle B.B. Jou
Independent Member of the Supervisory Board
G.E Schoolenberg
Independent Member of the Supervisory Board
Nils Bjoerkman
Member of the Supervisory Board
Click to see more

Key facts

  • EPIC
    -
  • Location
    Netherlands
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    NL0012047823
  • Market cap
    €147.12m
  • Employees
    262
  • Shares in issue
    79.68m
  • Exchange
    Euronext Amsterdam Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.